Anti C1q antibodies in cutaneous lupus erythematosus.

Department of Pathology, “Victor Babes” National Institute for Research and Development in Pathology and Biomedical Sciences, Bucharest, Romania Autoantibodies against C1q are strongly linked to immune-complex disorders like systemic lupus erythematosus (SLE). Although anti-C1q antibodies have received much interest in the recent years, their biological functions remain unclear. Anti-C1q antibodies are strongly associated with lupus nephritis. Recent studies describe apoptosis as a key player in LE pathogenesis and C1q is an important opsonin, playing a central role in the uptake of apoptotic blebs. The aim of this study was to evaluate serum anti C1q antibodies, C1q with circulating immune complexes and correlation between serology and cutaneous apoptosis in patients with cutaneous lupus erythematosus. Material and methods. 79 subjects were recruited and divided into 4 groups-13 healt hy controls, 26 with discoid chronic lupus (DLE), 23 with systemic lupus ery thematosus (SLE) and 17 with subacute lupus erythematosus (SCLE). Blood samples and skin punched-biopsy specimens were performed. Serum anti-C1q antibodies and C1q associated to the immune complexes concentrations were determined by ELISA. Cutaneous caspase-3 expression was evaluated by immunohistochemistry. Results. SLE and SCLE patients had significantly higher levels of anti-C1q antibodies and serum C1q-CIC levels when compared to healthy controls (p<0.05). Serum anti-C1q antibodies correlated with proteinuria in SLE patients (p<0.05). Anti C1q antibodies levels also correlated with cutaneous caspase 3 expression in SLE and SCLE patients (both p<0.05). Conclusions. Anti C1q antibodies might play a pathogenic role in SCLE pathogenesis and being positively associated with cutaneous apoptosis markers might be associated with a negative prognosis and secondary SLE development. Key words: Anti C1q antibodies, cutaneous lupus, circulating immune complexes.